Jpmorgan Chase & Co »

Astria Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $12M 1.7M 7.28
2025-03-31 $192k 36k 5.34
2024-12-31 $489k 55k 8.94
2024-09-30 $431k 39k 11.01
2024-06-30 $177k 19k 9.10
2024-03-31 $274k 20k 14.07
2023-12-31 $168k 22k 7.68
2023-09-30 $129k 17k 7.46
2023-06-30 $230k 28k 8.33